Publication

Effect of Meditation on Endothelial Function in Black Americans With Metabolic Syndrome: A Randomized Trial

Downloadable Content

Persistent URL
Last modified
  • 05/23/2025
Type of Material
Authors
    Viola Vaccarino, Emory UniversityKofi A. Kondwani, Morehouse School of MedicineMary Kelley, Emory UniversityNancy V. Murrah, Emory UniversityLinda Boyd, Morehouse School of MedicineYusuf Ahmed, Emory UniversityYuan X. Meng, Morehouse School of MedicineGary H. Gibbons, Morehouse School of MedicineW. Craig Hooper, Centers for Disease Control and PreventionChristine De Staercke, Centers for Disease Control and PreventionArshed Quyyumi, Emory University
Language
  • English
Date
  • 2013-07-01
Publisher
  • Lippincott, Williams & Wilkins
Publication Version
Copyright Statement
  • Copyright © 2013 by the American Psychosomatic Society.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0033-3174
Volume
  • 75
Issue
  • 6
Start Page
  • 591
End Page
  • 599
Grant/Funding Information
  • This study was supported by funding from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute U01 HL079156 and U01 HL79214; NIH, National Center for Research Resources (NCRR) Grant M01-RR00039 for the Emory General Clinical Research Center; NIH/NCRR 5P20RR11104 for the Morehouse Clinical Research Center; and NIH K24HL077506.
Abstract
  • OBJECTIVES: Psychological stress may play a role in metabolic syndrome. A consequence of metabolic syndrome is endothelial dysfunction, which is also influenced by psychological stress. We sought to compare the effect of consciously resting meditation (CRM), a sound based meditation, with a control intervention of health education (HE) on endothelial function in the setting of metabolic syndrome. METHODS: Sixty-eight black Americans with metabolic syndrome risk factors (age, 30-65 years) were randomized to either CRM (n = 33) or HE (n = 35); interventions were matched for frequency and duration of sessions and lasted 12 months. Endothelial function was assessed by brachial artery flow-mediated dilation at baseline and at 6 and 12 months. Arterial elasticity, metabolic risk factors, and psychosocial and behavioral variables were secondary end points. RESULTS: Although flow-mediated dilation improved in the CRM group for 12 months, this increase was not significantly higher than that in the HE group (p = .51 for the interaction between group and time). Non-endothelium- dependent dilation and arterial elasticity did not change in either group. Most metabolic syndrome risk factors showed beneficial trends in the CRM group only. A risk factor score counting the number of metabolic syndrome components decreased in the CRM group only (p = .049 for the interaction between treatment group and time). CONCLUSIONS: Among black Americans with metabolic syndrome risk factors, CRM, did not improve endothelial function significantly more than a control intervention of HE. CRM resulted in favorable trends in metabolic syndrome risk factors, which were examined as secondary outcomes.
Author Notes
  • Viola Vaccarino, MD, PhD, Emory University, Dept. of Epidemiology, Rollins School of Public Health, 1518 Clifton Rd NE, Room 3011, Atlanta, GA 30322, Phone: 404-727-8710; Fax: 404-727-8737; viola.vaccarino@emory.edu.
Keywords
Research Categories
  • Biology, Biostatistics
  • Health Sciences, Epidemiology
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items